Healthcare provider profile · identity verified

Bency Kurian, MD

Internal Medicine · DOWNERS GROVE, IL · NPI 1952581449

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	280	83
Atorvastatin Calcium	Atorvastatin Calcium	266	91
Amlodipine Besylate	Amlodipine Besylate	209	71
Losartan Potassium	Losartan Potassium	181	55
Simvastatin	Simvastatin	154	46
Omeprazole	Omeprazole	143	48
Metoprolol Succinate	Metoprolol Succinate	139	46
Lisinopril	Lisinopril	137	40
Rosuvastatin Calcium	Rosuvastatin Calcium	114	36
Metformin Hcl	Metformin Hcl	113	36
Hydrochlorothiazide	Hydrochlorothiazide	108	34
Zolpidem Tartrate	Zolpidem Tartrate	104	24
Alprazolam	Alprazolam	91	31
Pantoprazole Sodium	Pantoprazole Sodium	86	29
Gabapentin	Gabapentin	84	32
Escitalopram Oxalate	Escitalopram Oxalate	68	20
Metformin Hcl Er	Metformin Hcl	65	19
Tizanidine Hcl	Tizanidine Hcl	62	32
Jardiance	Empagliflozin	57	14
Meloxicam	Meloxicam	55	27
Prednisone	Prednisone	53	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	17
Albuterol Sulfate Hfa	Albuterol Sulfate	45	35
Trazodone Hcl	Trazodone Hcl	43	12
Azithromycin	Azithromycin	41	39
Enalapril Maleate	Enalapril Maleate	41	12
Montelukast Sodium	Montelukast Sodium	41	12
Alendronate Sodium	Alendronate Sodium	39	17
Ozempic	Semaglutide	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	12
Tramadol Hcl	Tramadol Hcl	38	15
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	28
Allopurinol	Allopurinol	36	11
Furosemide	Furosemide	36	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Glipizide Er	Glipizide	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Potassium Chloride	Potassium Chloride	33	13
Sertraline Hcl	Sertraline Hcl	33	17
Fluticasone Propionate	Fluticasone Propionate	32	15
Tamsulosin Hcl	Tamsulosin Hcl	31	14
Buspirone Hcl	Buspirone Hcl	29	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	29	12
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Lorazepam	Lorazepam	25	12
Estradiol	Estradiol	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Famotidine	Famotidine	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	19
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Baclofen	Baclofen	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Eliquis	Apixaban	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Methylprednisolone	Methylprednisolone	12	11
Celecoxib	Celecoxib	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error